Refractory CRPS pain treated with psilocybin: A case report
David S Jevotovsky, Harman Chopra, Court Wing, Carlton J Spotswood, Joel Castellanos
Clinical Case Reports September 1, 2024 DOI: 10.1002/ccr3.9421 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A patient with refractory complex regional pain syndrome |
| Intervention | Psilocybin |
| Topics | Psilocybin Psychedelic-assisted therapy |
| Keywords | Medical research Chronic pain Psychedelics Pain management Crps |
| Citations | 9 |
| Key findings | Psilocybin provided significant pain relief and functional improvement in a patient with treatment-resistant CRPS. |
Abstract
Key Clinical Message Psilocybin shows promise as a treatment for CRPS, offering significant pain relief and functional improvement in a patient with refractory symptoms. This case highlights the need for further research into psilocybin's efficacy and optimal dosing for chronic pain management.
Comparable studies
Other case reports and case series on psilocybin and psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report | 2025 | Case study | |
| Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report 60-year-old man with recurrent depression and history of delusions | 2025 | Case study | n = 1 |
| Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin—A retrospective case study A woman in her early forties with early complex trauma and treatment-resistant depression | 2023 | Case report | n = 1 |
| Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use A 36-year-old transwoman who was a daily methamphetamine user | 2024 | Case study | n = 1 |
| Long‐COVID symptoms improved after MDMA and psilocybin therapy: A case report 41-year-old fully vaccinated female with Long-COVID syndrome | 2024 | Case report | n = 1 |